SMi Group reports (07.01.2016, London): SMi caught up with key speaker Deborah Lee, VP of Clinical Development from INSYS Therapeutics, Inc.
SMi's 10th annual Paediatric Clinical Trials Conference and Exhibition, takes place in London, UK, on the 16th and 17th of March 2016. The conference will feature a series of interactive sessions, roundtables and panel discussion facilitated by leading industry experts which will provide executives with useful tools and best practices to develop analgesics in paediatric population, implement a strategy regulatory partnership through collaboration, explore innovations in drug formulation, monitor and audit issues specific to paediatric research and utilize clinical pharmacology to model adult data to paediatrics.
To register or to find further information on the full agenda, please visit www.paediatric-trials.co.uk
In the run up to the conference, SMi Group interviewed key speaker Deborah Lee, VP of Clinical Development from INSYS Therapeutics, Inc. who will be presenting on Day One of the event. Deborah's presentation entitled 'Developing Paediatric Trials in the US' will cover the following topics:
- Negotiation with FDA
- Use of patient advocacy group
- Logistical difficulties with academic
Here is a snapshot of the pre-conference interview with Deborah:
"SMi: Why are you attending this conference?
D.L.: We need to get the message out on how important it is to do trials for paediatric diseases. Treating Alzheimer's disease may improve life for patients for the last few (non-productive) years of their life but intervening in paediatric refractory epilepsy has the potential of making a difference for 60-70 years of life."
The interview will cover Deborah's current role; challenges in the field; the main issues in paediatric clinical trials and much more. To download the full interview please visit the downloads tab at www.paediatric-trials.co.uk
As well as supplying attendees with the latest information on paediatric clinical trials, the 2016 event will provide the opportunity to take part in a full day pre-conference workshop entitled 'Drug development in the paediatric population'. This pre-conference workshop will give an introduction into the background of paediatric legislation both in the USA and in the EU. It will further discuss the key differences between the adult and the child's body, and the consequences in different absorption, distribution, metabolisation and excretion (ADME) in the different age groups.
For sponsorship enquiries, contact Alia Malick at +44 (0) 7827 6168 or email email@example.com
For media enquiries contact Anna Serazetdinova on +44 (0) 20 7827 6180 or email firstname.lastname@example.org
For delegate enquires or to register contact Matthew Apps on +44 (0) 20 7827 6093 or email email@example.com